K Pharma,Inc.

K Pharma, Inc., headquartered in Minato, Japan, was established in 2016 and operates within the Japanese market. The company is dedicated to the research, development, production, and sale of both regenerative medicines and pharmaceutical products. A key focus within their regenerative medicine efforts involves leveraging disease-specific induced pluripotent stem (iPS) cell technology, primarily to develop treatments for conditions such as spinal cord injuries and cerebral infarctions.

صناعة

Biotechnology

قطاع

Healthcare

المقر الرئيسي

JP

المدير التنفيذي

Komei Fukushima

المدرجة منذ ذلك الحين

17 أكتوبر 2023

موظفين

20